177 related articles for article (PubMed ID: 38419127)
1. The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathway.
Zhai P; Chen Q; Wang X; Ouyang X; Yang M; Dong Y; Li J; Li Y; Luo S; Liu Y; Cheng X; Zhu R; Hu D
Chin Med; 2024 Feb; 19(1):34. PubMed ID: 38419127
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction.
Chai R; Ye Z; Xue W; Shi S; Wei Y; Hu Y; Wu H
Front Cell Dev Biol; 2023; 11():1252942. PubMed ID: 37766966
[No Abstract] [Full Text] [Related]
3. Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
Shi H; Zhou P; Gao G; Liu PP; Wang SS; Song R; Zou YY; Yin G; Wang L
J Food Biochem; 2021 Jul; 45(7):e13757. PubMed ID: 34032295
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways.
Yin B; Hou XW; Lu ML
Acta Pharmacol Sin; 2019 May; 40(5):599-607. PubMed ID: 30030530
[TBL] [Abstract][Full Text] [Related]
5. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibited intermittent hypoxia induced neuronal injury through promoting autophagy via AMPK-mTOR signaling pathway.
Si J; Liu B; Qi K; Chen X; Li D; Yang S; Ji E
J Ethnopharmacol; 2023 Oct; 315():116677. PubMed ID: 37268259
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway.
Yuan X; Jing S; Wu L; Chen L; Fang J
Exp Ther Med; 2014 Sep; 8(3):973-977. PubMed ID: 25120632
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia-Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity.
Yao H; Xie Q; He Q; Zeng L; Long J; Gong Y; Li X; Li X; Liu W; Xu Z; Wu H; Zheng C; Gao Y
Oxid Med Cell Longev; 2022; 2022():9626703. PubMed ID: 35669855
[TBL] [Abstract][Full Text] [Related]
9. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats.
Fei YX; Wang SQ; Yang LJ; Qiu YY; Li YZ; Liu WY; Xi T; Fang WR; Li YM
J Ethnopharmacol; 2017 Jul; 207():57-66. PubMed ID: 28645780
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of MAPK signaling pathway mediated by ITGB3 gene silencing on myocardial ischemia-reperfusion injury in mice and its mechanism.
Wang MC; Wang D; Lu YH; Li ZH; Jing HY
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):820-836. PubMed ID: 33577037
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
Li Q; Shen L; Wang Z; Jiang HP; Liu LX
Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
[TBL] [Abstract][Full Text] [Related]
13. Sappanone A Protects Against Myocardial Ischemia Reperfusion Injury by Modulation of Nrf2.
Shi X; Tao G; Ji L; Tian G
Drug Des Devel Ther; 2020; 14():61-71. PubMed ID: 32021092
[TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis
Yan J; Li Z; Liang Y; Yang C; Ou W; Mo H; Tang M; Chen D; Zhong C; Que D; Feng L; Xiao H; Song X; Yang P
Food Funct; 2023 Nov; 14(22):10052-10068. PubMed ID: 37861458
[No Abstract] [Full Text] [Related]
15. Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway.
Yin F; Zhou H; Fang Y; Li C; He Y; Yu L; Wan H; Yang J
J Ethnopharmacol; 2020 Feb; 248():112319. PubMed ID: 31639488
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1.
Hu T; Zou HX; Le SY; Wang YR; Qiao YM; Yuan Y; Liu JC; Lai SQ; Huang H
Int J Mol Med; 2023 Nov; 52(5):. PubMed ID: 37800609
[TBL] [Abstract][Full Text] [Related]
17. A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.
Zheng Q; Zhu JZ; Bao XY; Zhu PC; Tong Q; Huang YY; Zhang QH; Zhang KJ; Zheng GQ; Wang Y
Front Physiol; 2018; 9():795. PubMed ID: 30018562
[TBL] [Abstract][Full Text] [Related]
18. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
19. Janus kinase/signal transducer and activator of transcription inhibitors enhance the protective effect mediated by tanshinone IIA from hypoxic/ischemic injury in cardiac myocytes.
Zhang MQ; Tu JF; Chen H; Shen Y; Pang LX; Yang XH; Sun RH; Zheng YL
Mol Med Rep; 2015 Apr; 11(4):3115-21. PubMed ID: 25502794
[TBL] [Abstract][Full Text] [Related]
20. Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway.
Wang D; Wang D; Jin Q; Wang X
Phytomedicine; 2024 Mar; 125():155359. PubMed ID: 38301300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
